🔗 Share this article

Given that the US proceeds with sweeping adjustments to its vaccination schedules, a particular individual appears somewhat surprisingly: Tracy Beth Høeg, a US-based sports medicine doctor and epidemiologist who initially gained attention by questioning coronavirus vaccines in the global health crisis and has concentrated on possible deaths after Covid vaccination in her brief time at the FDA.

Scheduled Changes to Childhood Vaccine Schedule

Agency leaders had intended to reveal radical revisions to the childhood vaccination calendar earlier this month, aligning the US with Denmark’s immunization schedule, it is understood – a significant shift that would place the US out of alignment with many the international standard with little proof for public health gain. This reveal has been postponed until the coming year.

In place of the top vaccines chief, Tracy Beth Høeg is scheduled to speak at the meeting. She was newly appointed temporary leader of the FDA’s Center for Drug Evaluation and Research (CDER), the fifth individual to run the office this year.

A Shift at the Regulatory Body

Høeg's temporary position could signify a strengthened alliance between the drug and vaccine divisions as Høeg and Prasad consolidate power at the agency – and it signals a renewed priority upon reevaluating already-approved immunizations at the FDA.

The new acting director has frequently advocated for halting certain childhood shot schedules in the US in order to be more in line with Denmark's approach, a society with universal health coverage and a number of inhabitants approximately the size of the state of Wisconsin.

To date comments, she has continued to focus on immunizations – usually the purview of Dr. Prasad, chief of the FDA’s vaccine center – rather than drug regulation.

Concerns Over Expertise

Høeg has no obvious experience in medication creation, regulation or management, which has been customary for former leaders of the CBER. She has worked at the FDA as a top consultant to the commissioner and the vaccine center since earlier this year.

“She doesn’t seem to have the necessary background” for running the CDER, remarked Jonathan Howard. “She lacks experience running a scientific study. She is not versed in managing a major agency. She has no expertise in pharmaceutical oversight.”

Previous commissioners of the center would “grasp legal statutes and the underlying principles of drug development”, commented Dr. Janet Woodcock. “Clearly, she lacks the type of experience that former directors who headed CBER have had.”

This division has an vast range of responsibilities at the FDA, Woodcock stated.

“Many people just zeroes in on the novel medication approvals, but the generic drug division authorizes a multitude of generic drugs. There’s a biosimilars program, over-the-counter program and other areas, and every single one must be managed,” Woodcock explained. “The thing you don’t keep your eye on, that is precisely what that I always told people is going to bite you.”

Furthermore, a substantial management element to the role, which manages over 5,000 staff members. “It is a enormous management job, if you perform it correctly,” Woodcock concluded.

Agency Reaction and Controversial Policies

Regarding concerns about Dr. Høeg's credentials and whether this assignment indicates increased cooperation among agency officials on vaccines, a representative responded that the “inquiries rely on incorrect premises”.

“This background is consistent with the responsibilities of her job,” the official stated, citing the period Dr. Høeg spent counseling the agency head on “medication safety and oversight research, including computerized risk analysis and vaccine surveillance”.

As the temporary head, Høeg assumes responsibility for the commissioner’s recently launched priority voucher program, a controversial expedited drug-approval program that apparently concerned her former heads. “By what process are these medications being selected for this fast-track system? Who takes the calls?” Dr. Howard said. “There is a lot of confidentiality occurring at the regulatory body right now.”

Broadly speaking, he stated, “the agency appears to be shifting towards more relaxed regulations of most medications, except for immunizations.”

Documented History on Immunizations

Concerning vaccines, Dr. Høeg has a more established, if troubling, past, some experts have noted. She published a study using non-validated crowd-sourced reports to determine the frequency of heart inflammation after COVID-19 immunization. She consulted for the state of Florida surgeon general Joseph Ladapo, who reportedly have altered data to indicate COVID-19 vaccinations are pose a greater threat than they are.

Included in her “desired changes” for the new federal leadership included altering guidelines for new vaccines and ending “non-essential” immunizations, she stated post-election on a podcast. At the FDA, Dr. Høeg has according to sources suggested preventing young men from obtaining Covid vaccinations.

“She is an complete true believer who commences with her beliefs and tailors the evidence to fit the data in a highly deceptive, fraudulent manner,” Howard stated.

Taking Control and a “Campaign of Retribution”

Høeg aligned with other contrarians, {like|